Aktie IMP IMEXPHARM CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Imexpharm Corporation

Aktien

IMP

VN000000IMP0

IMP

Schlusskurs Ho Chi Minh S.E.
Andere Börsenplätze
 00:00:00 28.06.2024 		% 5 Tage % 1. Jan.
75’300 VND +0.40% Intraday Chart für Imexpharm Corporation +3.15% +33.04%
27.05. Imexpharm Corporation ernennt Tnrong Minh Hung, ein nicht-exekutives Mitglied des Board of Directors, zum Mitglied des Audit Committee unter dem Board of Directors CI
19.04. Imexpharm Corporation meldet Ergebniszahlen für das erste Quartal zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Imexpharm Corporation announced that it has received funding from SK Group Ltd.
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Imexpharm Corporation Announces Personnel Change
Imexpharm Corporation Announces Cash Dividend for 2021, Payable on June 24, 2022
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. IMP Aktie
  4. Nachrichten Imexpharm Corporation
  5. Andere Sprachen